Picture of Alliance Pharma logo

APH — Alliance Pharma Share Price

0.000.00%
gb flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Momentum

Relative Strength (%)
1m+4.4%
3m+5.42%
6m+5.13%
1yr+12.83%
Volume Change (%)
10d/3m+24.46%
Price vs... (%)
52w High-9.27%
50d MA+6.67%
200d MA+9.26%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)17.44
PEG Ratio (f)1.97
EPS Growth (f)9.72%
Dividend Yield (f)1.49%
Valuation (ttm)IndustryMarket
Price to Book Value2.14
Price to Tang. Bookn/a
Price to Free Cashflow18.53
Price to Sales4.09
EV to EBITDA16.92

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital6.89%
Return on Equity6.52%
Operating Margin22.34%

Financial Summary

Year End 31st DecUnit201620172018201920202021E2022ECAGR / Avg
Total Revenue£m97.49101.64118.21135.64129.8167.47184.2721.84%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+35.94+28.93-2.03+7.34-17.09+35.84+9.72n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for APH

Alliance Pharma hits 52w high – but will it continue? background image

Alliance Pharma hits 52w high – but will it continue?

It's a good time to be a shareholder in Alliance Pharma (LON:APH): as the share approaches its 52-week high, holders may be wondering whether to sell and take the profit, or buy more and ride the uptrend. Shares in Alliance Pharma are...

Alliance Pharma share price hits a new 52 week high background image

Alliance Pharma share price hits a new 52 week high

Shares in Alliance Pharma (LON:APH) are currently trading close to a 52 week high, with the share price up by around 5.17% to 103.8p over the past week. On a one-month basis, the Alliance Pharma price has risen by 4.32%. For investors...

Alliance Pharma share price hits a one-year high background image

Alliance Pharma share price hits a one-year high

Shares in Alliance Pharma (LON:APH) are currently trading close to a 52 week high, with the share price up by around 2.40% to 98.1p over the past week. On a one-month basis, the Alliance Pharma price has risen by 2.72%. For investors h...

Alliance Pharma (LON:APH): buy, sell or hold? background image

Alliance Pharma (LON:APH): buy, sell or hold?

Shares in Alliance Pharma (LON:APH) are currently trading close to a 52 week high, with the share price up by around 2.78% - to 95.772 - over the past week. On a one-month basis, the Alliance Pharma share price has risen by 13.5%. For...

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202131st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2021 / 2022

Blurred out image of Alliance Pharma EPS forecast chart

Profile Summary

Alliance Pharma plc is a United Kingdom-based holding company. The Company is primarily engaged in the acquisition, marketing and distribution of healthcare and pharmaceutical products. It is focused on two areas, which include Consumer Healthcare brands and Prescription Medicines. The Company’s Consumer Healthcare brands include Kelo-Cote, Nizoral, Amberen, MacuShield, Vamousse and Aloclair. Its Prescription Medicines include Hydromol, Flamma Franchise and Forceval. Its brands also include Ashton & Parsons and Anbesol. The Company’s products include Alliance Calcium Syrup, Amantadine hydrochloride, Aiweidi, Biodermatin, Biotaches, Buccastem M, Changmin, Decapional, Dermachronic, Dermacide, Dervida, Effadiane, Fazol, Gen-Ongles, Irenat, ISIB, Isocarboxazid, Jonctum, Kelo-Stretch, Lypsyl, Lefuzhi, Malunjunshe, MolluDab, Menadiol, Neostigmine and Nu-Seals. Its geographical area includes Europe, Middle East and Africa (EMEA), Asia Pacific and China (APAC) and Americas (AMER).

Directors

Last Annual
December 31st, 2020
Last Interim
June 30th, 2021
Incorporated
June 26th, 2001
Public Since
November 22nd, 2001
No. of Employees
221
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
gb flag iconLondon Stock Exchange
Shares in Issue
538,225,524

APH Share Price Performance

Similar to APH

Picture of Abcam logo

Abcam

gb flag iconLondon Stock Exchange

Picture of Animalcare logo

Animalcare

gb flag iconLondon Stock Exchange

Picture of AstraZeneca logo

AstraZeneca

gb flag iconLondon Stock Exchange

Picture of Benchmark Holdings logo

Benchmark Holdings

gb flag iconLondon Stock Exchange

Picture of Beximco Pharmaceuticals logo

Beximco Pharmaceuticals

gb flag iconLondon Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email